Assist. Prof. Dr. Malihe Pooresmaeil | Drug Delivery | Women Researcher Award

Published on by Chemistry Awards

Assist. Prof. Dr. Malihe Pooresmaeil | Drug Delivery | Women Researcher Award

Assist. Prof. Dr. Malihe Pooresmaeil | Assistant Professor | University Of Zanjan | Iran

Assist. Prof. Dr. Malihe Pooresmaeil is a distinguished researcher in the field of organic chemistry, specializing in the design, synthesis, and application of advanced polymeric, nanocomposite, and biopolymer-based drug delivery systems. Her work integrates organic synthesis with nanotechnology to develop stimuli-responsive, pH-sensitive, and biocompatible platforms for targeted therapy, particularly in cancer treatment. She has made significant contributions to the functionalization of graphene oxide, metal-organic frameworks (MOFs), covalent organic frameworks (COFs), and natural polymers such as starch, carboxymethyl cellulose, and chitosan, enabling controlled and efficient drug delivery. Dr. Pooresmaeil’s research also encompasses the development of antimicrobial and photoluminescent nanocomposites, hydrogels, and multi-functional hybrid materials with biomedical and environmental applications. Her innovative work has been widely recognized, reflected in her extensive publication record of over 63 documents, cited more than 2,668 times, with an h-index of 30 and an i10-index of 51 (Google Scholar), alongside a Scopus h-index of 32 and over 3,060 citations. She has been consistently acknowledged among the top 2% most cited scientists by Stanford University. Dr. Pooresmaeil’s research has appeared in high-impact journals, demonstrating her leadership in advancing polymeric and nanostructured materials for healthcare applications, while her work on stimuli-responsive drug delivery, biopolymer modification, and MOF/COF-based systems has influenced both academic research and practical applications in biomedical sciences.

Profile : Google Scholar | Scopus | Orcid 

Featured Publications :

  • Pooresmaeil, M., Namazi, H., & Salehi, R. (2022). Photoluminescent and biocompatible starch coated bio-based-derived carbon dots as a promising platform for methotrexate delivery. European Polymer Journal, 158, 110698.

  • Pooresmaeil, M., Namazi, H., & Javanbakht, S. (2019). Green one-pot synthesis of carboxymethylcellulose/Zn-based metal-organic framework/graphene oxide bio-nanocomposite as a nanocarrier for drug delivery system. Carbohydrate Polymers, 219, 255-266.

  • Pooresmaeil, M., Namazi, H., & Salehi, R. (2022). Dual anticancer drug delivery of D-galactose-functionalized stimuli-responsive nanogels for targeted therapy of the liver hepatocellular carcinoma. European Polymer Journal, 165, 111104.

  • Pooresmaeil, M., Namazi, H., & Asl, E. A. (2021). Simple fabrication of biocompatible chitosan/graphene oxide microspheres for pH-controlled amoxicillin delivery. European Polymer Journal, 150, 110425.

  • Pooresmaeil, M., Namazi, H., & Hosseyni, R. (2020). Star-shaped polylactic acid based on triazine dendrimers; Investigation of catalyst type and time factors on the polylactic acid molecular weight. Iranian Polymer Journal, 29, 987-998.

Assoc. Prof. Dr. Ningbo Li | Medicinal Chemistry | Best Researcher Award

Published on by Chemistry Awards

Assoc. Prof. Dr. Ningbo Li | Medicinal Chemistry | Best Researcher Award

Assoc. Prof. Dr. Ningbo Li , Medicinal Chemistry , Shanxi Medical University, China

Dr. Ningbo Li is an accomplished Associate Professor at the School of Basic Medical Sciences, Shanxi Medical University, with a strong academic foundation and a passion for cancer research. With a doctorate in Organic Chemistry from Hunan University, Dr. Li has built a reputable career in green synthesis, targeted nano-drug delivery systems, and near-infrared fluorescent probes molecule for cancer diagnostics and therapy. He has led over 10 national and provincial research projects, published 46 SCI-indexed papers, and holds 5 authorized patents. Dr. Li also contributes to academia through textbooks and serves as a Young Editorial Board Member of Journal of Xiangtan University. His collaborations span leading institutions like Hunan University and Nankai University. With 863 citations and rising influence, Dr. Li is committed to pioneering innovative, low-toxicity cancer therapeutics and translating lab findings into clinical advances.

Professional Profile : 

Orcid   

Scopus 

Summary of Suitability for Award:

Dr. Ningbo Li, Associate Professor at Shanxi Medical University, has demonstrated exceptional research productivity and innovation in the fields of organic chemistry, nanomedicine, and cancer therapeutics. With over 50 SCI-indexed publications, 5 authorized patents, and leadership on more than 10 national and provincial-level research projects, Dr. Li has made significant contributions to targeted cancer treatment and green synthesis of anti-tumor agents. His pioneering work on magnetic nano-drug delivery systems and near-infrared fluorescent probes molecule showcases translational potential for clinical applications in oncology. Furthermore, his involvement in academic book publications, editorial duties, and inter-institutional collaborations reflects both leadership and scholarly impact. With a citation index of 863 and consistent innovation through funded research, Dr. Li exemplifies the qualities of a top-tier researcher. Dr. Ningbo Li is highly suitable for the “Best Researcher Award”, as he meets and exceeds the criteria in terms of research excellence, innovation, scientific impact, and societal relevance. His dedication to advancing cancer research through interdisciplinary chemistry and his strong track record in publications, patents, and funded projects make him a deserving and outstanding candidate for this prestigious recognition

🎓Education:

Dr. Ningbo Li’s academic journey began with a Bachelor’s degree in Chemistry from Shanxi Datong University (2005–2009). He pursued his postgraduate studies at Hunan University, earning a Master’s degree (2009–2012) and subsequently a Ph.D. in Organic Chemistry (2012–2015). His academic training emphasized organometallic chemistry, chiral complex synthesis, and catalysis, laying the groundwork for his future research in drug development and nanomedicine. During his doctoral studies, Dr. Li specialized in chiral Lewis acids, exploring their role in asymmetric synthesis—an area critical to pharmaceutical innovation. His graduate work was pivotal in shaping his later focus on bio-compatible metal complexes and tumor-targeted drug delivery platforms. The integration of organic synthesis with biomedical applications became a hallmark of his educational path, culminating in a multidisciplinary approach that bridges chemistry, nanotechnology, and medical science.

🏢Work Experience:

Dr. Ningbo Li began his academic career as a Lecturer (2015–2018) at the School of Basic Medical Sciences, Shanxi Medical University, where he conducted interdisciplinary research and mentored students. In December 2018, he was promoted to Associate Professor, reflecting his growing contributions to research and teaching. With over a decade in academia, he has supervised numerous graduate projects and continues to develop innovative strategies for targeted cancer therapy using nanomaterials and fluorescent probes. Dr. Li has consistently received competitive research funding from the National Natural Science Foundation of China and the Shanxi Provincial Science Foundations. He also actively contributes to national teaching excellence through authorship in leading organic chemistry textbooks. His dedication to both scientific advancement and student development underscores a career that blends high-impact research with academic leadership in medical and chemical sciences.

🏅Awards: 

While specific named awards are not detailed, Dr. Ningbo Li’s academic honors are evident through his prestigious research grants, editorial board appointment, and book contributions. He is the Principal Investigator for multiple national-level research projects, including NSFC Young Scholar Awards, which are highly competitive and indicative of early-career excellence. His appointment as a Young Editorial Board Member of the Journal of Xiangtan University (Natural Science Edition) further reflects his scientific influence and peer recognition. Dr. Li’s patents on chiral zirconium and titanium complexes also highlight his innovative contributions to chemical synthesis. Moreover, his extensive publishing record and the high citation index (863) attest to the impact of his research in organic and medicinal chemistry. Through his involvement in writing authoritative textbooks used in higher education, Dr. Li has contributed significantly to the academic development of students and educators in China.

🔬Research Focus:

Dr. Ningbo Li’s research is centered on the interdisciplinary interface of organic chemistry, nanotechnology, and cancer therapeutics, with a strong emphasis on green and sustainable chemistry. His primary focus lies in the design and synthesis of functionalized magnetic nanocomposites and near-infrared fluorescent probe molecules for the precise diagnosis and targeted treatment of malignant tumors. By engineering magnetic-targeted nano-drug delivery systems, his team aims to achieve site-specific drug accumulation, minimizing systemic toxicity and enhancing therapeutic efficacy. Another key area involves the green synthesis of novel bioactive compounds, particularly chiral organometallic complexes, which exhibit promising anti-tumor properties. His group also explores chiral Lewis acids as catalysts in asymmetric reactions, crucial for the development of structurally complex pharmaceuticals. Dr. Li’s research is highly translational, striving to bridge the gap between bench and bedside by accelerating the clinical application of biocompatible, efficient, and low-toxicity cancer therapeutics rooted in advanced chemical innovation.

Publication Top Notes:

1. g-C₃N₄-Based Heterogeneous Photocatalyzed Synthesis and Evaluation of Antitumor Activities of Fluoroalkylated 4H-Pyrido[1,2-a]pyrimidin-4-ones

2. Magnetic Nanocarriers for pH/GSH/NIR Triple-Responsive Drug Release and Synergistic Therapy in Tumor Cells

3. GSH-Responsive Magnetic Mesoporous Silica Nanoparticles for Efficient Controlled Drug Delivery in Tumor Cells

 

​

Asmaa Hamouda | Medicinal Chemistry | Best Researcher Award

Published on by Chemistry Awards

Dr. Asmaa Hamouda | Medicinal Chemistry | Best Researcher Award

Doctorate at Alexandria University, Egypt

Asmaa F. Hamouda is an accomplished biochemist with over a decade of experience in teaching and research, focusing on medical biochemistry and lifestyle-related disorders. A breast cancer survivor, she is deeply committed to patient education and support, particularly in disease management. Based in Egypt, Asmaa has authored 25 books and published 30 scientific papers, making significant contributions to her field. Her diverse experiences include roles at prestigious universities and clinical settings.

Author Metrics

Scopus Profile

ORCID Profile

Google Scholar Profile

Asmaa has achieved considerable recognition in the academic community, evidenced by a robust citation record on platforms such as Google Scholar. Her research impact is reflected in her numerous publications and her active engagement in scientific discourse, highlighting the significance of her contributions to biochemistry and nutrition.

  • Citations: 48
  • Documents: 7
  • h-index: 4

Education

Asmaa holds a PhD in Biochemistry from Alexandria University, earned in January 2013, where she graduated with distinction. She also completed her Master’s degree in Biochemistry in October 2007 and her Bachelor of Science in Biochemistry/Chemistry in May 2003, both from the same institution. In 2021, she further enhanced her expertise by obtaining a professional certification in Functional Medicine and Nutrition.

Research Focus

Her research primarily investigates the biochemical mechanisms underlying lifestyle diseases and the role of nutrition in health management. Asmaa is particularly interested in exploring natural compounds for disease prevention and treatment, aiming to bridge the gap between biochemistry and practical health solutions.

Professional Journey

Asmaa began her career as a demonstrator at Alexandria University, gradually advancing to positions such as lecturer and assistant professor at universities in Saudi Arabia. Currently, she serves as a nutrition advisor, leveraging her academic expertise to support patients in managing their health through tailored nutritional strategies.

Honors & Awards

Throughout her career, Asmaa has received numerous accolades for her contributions to teaching and research. Her work has been recognized at various international conferences, where she has been invited to speak and present, underscoring her influence and leadership in the field of biochemistry.

Publications Noted & Contributions

Asmaa has authored a variety of influential publications in reputable scientific journals, with key studies focusing on the biochemical effects of natural extracts. Her research on the therapeutic potential of compounds like pomegranate and avocado has drawn attention, showcasing innovative approaches to managing chronic diseases.

Investigating Grape Seed Extract as a Natural Antibacterial Agent for Water Disinfection in Saudi Arabia: A Pilot Chemical, Phytochemical, Heavy-Metal, Mineral, and CB-Dock Study Employing Water and Urine Samples

Identification of Effective Anti-HCV and Anti-HIV Royal Jelly Constituents and Their Acute Toxicity Evaluation in Albino Rats

  • Journal: Food and Chemical Toxicology
  • Date: 2023-12
  • DOI: 10.1016/j.fct.2023.114170
  • Contributors: Noha H. Habashy, Asmaa F. Hamouda, Marwa M. Abu Serie

A Bio-Indicator Pilot Study Screening Selected Heavy Metals in Female Hair, Nails, and Serum from Lifestyle Cosmetic, Canned Food, and Manufactured Drink Choices

Biochemical Pilot Study on Effects of Pomegranate Seed Oil Extract and Cosmetic Cream on Neurologically Mediated Skin Inflammation in Animals and Humans: A Comparative Observational Study

A Pilot Study of the Amelioration of Avocado Seed Oil in Obese Female Rats Induced by Carbon Tetrachloride and Alloxan Monohydrate

  • Journal: Journal of Drug and Alcohol Research
  • Date: 2022
  • Contributors: Asmaa Fathi Hamouda

 Research Timeline

Her research journey spans several significant projects, from her doctoral studies to her ongoing work as a nutrition advisor. Asmaa has consistently contributed to the academic literature, providing valuable insights into the role of biochemistry in health and disease management.

Collaborations and Projects

Asmaa has engaged in numerous collaborations with institutions and researchers across the globe. Her participation in international conferences has fostered partnerships in the fields of biochemistry and nutrition, enhancing the impact and reach of her research efforts.

Conclusion

Dr. Asmaa Hamouda exemplifies excellence in the field of medicinal chemistry and biochemistry. Her robust publication record, innovative research, and commitment to patient education highlight her as a leading figure in the academic community. While she has achieved significant recognition, focusing on collaboration, visibility, and public engagement can further enhance her impact. With her dedication and expertise, Asmaa is well-positioned to continue making meaningful contributions to health management and disease prevention.